Global Acinetobacter Infections Treatment Market Size, Status and Forecast 2023

Report ID: 1234879 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Sulbactam
        1.2.3 Carbapenems
        1.2.4 Aminoglycosides
        1.2.5 Polymyxins
        1.2.6 Tetracyclines
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Acinetobacter Infections Treatment Market Share by Pipeline: 2016 VS 2021 VS 2027
        1.3.2 ETX2514
        1.3.3 Nacubactam RG6080
        1.3.4 Arenicin
        1.3.5 VXD-001
        1.3.6 Small Molecule Antibiotic
        1.3.7 AR-401 mAB
        1.3.8 LCB01-0371 (PO)
        1.3.9 GN-4474
        1.3.10 Antibacterial Antibody
        1.3.11 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Acinetobacter Infections Treatment Market Perspective (2016-2027)
    2.2 Acinetobacter Infections Treatment Growth Trends by Regions
        2.2.1 Acinetobacter Infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Acinetobacter Infections Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Acinetobacter Infections Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Acinetobacter Infections Treatment Industry Dynamic
        2.3.1 Acinetobacter Infections Treatment Market Trends
        2.3.2 Acinetobacter Infections Treatment Market Drivers
        2.3.3 Acinetobacter Infections Treatment Market Challenges
        2.3.4 Acinetobacter Infections Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Acinetobacter Infections Treatment Players by Revenue
        3.1.1 Global Top Acinetobacter Infections Treatment Players by Revenue (2016-2021)
        3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Acinetobacter Infections Treatment Revenue
    3.4 Global Acinetobacter Infections Treatment Market Concentration Ratio
        3.4.1 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2020
    3.5 Acinetobacter Infections Treatment Key Players Head office and Area Served
    3.6 Key Players Acinetobacter Infections Treatment Product Solution and Service
    3.7 Date of Enter into Acinetobacter Infections Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Acinetobacter Infections Treatment Breakdown Data by Type
    4.1 Global Acinetobacter Infections Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2022-2027)

5 Acinetobacter Infections Treatment Breakdown Data by Pipeline
    5.1 Global Acinetobacter Infections Treatment Historic Market Size by Pipeline (2016-2021)
    5.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2022-2027)

6 North America
    6.1 North America Acinetobacter Infections Treatment Market Size (2016-2027)
    6.2 North America Acinetobacter Infections Treatment Market Size by Type
        6.2.1 North America Acinetobacter Infections Treatment Market Size by Type (2016-2021)
        6.2.2 North America Acinetobacter Infections Treatment Market Size by Type (2022-2027)
        6.2.3 North America Acinetobacter Infections Treatment Market Size by Type (2016-2027)
    6.3 North America Acinetobacter Infections Treatment Market Size by Pipeline
        6.3.1 North America Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
        6.3.2 North America Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027)
        6.3.3 North America Acinetobacter Infections Treatment Market Size by Pipeline (2016-2027)
    6.4 North America Acinetobacter Infections Treatment Market Size by Country
        6.4.1 North America Acinetobacter Infections Treatment Market Size by Country (2016-2021)
        6.4.2 North America Acinetobacter Infections Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Acinetobacter Infections Treatment Market Size (2016-2027)
    7.2 Europe Acinetobacter Infections Treatment Market Size by Type
        7.2.1 Europe Acinetobacter Infections Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Acinetobacter Infections Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Acinetobacter Infections Treatment Market Size by Type (2016-2027)
    7.3 Europe Acinetobacter Infections Treatment Market Size by Pipeline
        7.3.1 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
        7.3.2 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027)
        7.3.3 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2016-2027)
    7.4 Europe Acinetobacter Infections Treatment Market Size by Country
        7.4.1 Europe Acinetobacter Infections Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Acinetobacter Infections Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Acinetobacter Infections Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Acinetobacter Infections Treatment Market Size by Type
        8.2.1 Asia-Pacific Acinetobacter Infections Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Acinetobacter Infections Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Acinetobacter Infections Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Acinetobacter Infections Treatment Market Size by Pipeline
        8.3.1 Asia-Pacific Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
        8.3.2 Asia-Pacific Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027)
        8.3.3 Asia-Pacific Acinetobacter Infections Treatment Market Size by Pipeline (2016-2027)
    8.4 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region
        8.4.1 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Acinetobacter Infections Treatment Market Size (2016-2027)
    9.2 Latin America Acinetobacter Infections Treatment Market Size by Type
        9.2.1 Latin America Acinetobacter Infections Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Acinetobacter Infections Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Acinetobacter Infections Treatment Market Size by Type (2016-2027)
    9.3 Latin America Acinetobacter Infections Treatment Market Size by Pipeline
        9.3.1 Latin America Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
        9.3.2 Latin America Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027)
        9.3.3 Latin America Acinetobacter Infections Treatment Market Size by Pipeline (2016-2027)
    9.4 Latin America Acinetobacter Infections Treatment Market Size by Country
        9.4.1 Latin America Acinetobacter Infections Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Acinetobacter Infections Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Acinetobacter Infections Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type
        10.2.1 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline
        10.3.1 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
        10.3.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027)
        10.3.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2016-2027)
    10.4 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country
        10.4.1 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Entasis Therapeutics
        11.1.1 Entasis Therapeutics Company Details
        11.1.2 Entasis Therapeutics Business Overview
        11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Introduction
        11.1.4 Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.1.5 Entasis Therapeutics Recent Development
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche Acinetobacter Infections Treatment Introduction
        11.2.4 Roche Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.2.5 Roche Recent Development
    11.3 Adenium Biotech
        11.3.1 Adenium Biotech Company Details
        11.3.2 Adenium Biotech Business Overview
        11.3.3 Adenium Biotech Acinetobacter Infections Treatment Introduction
        11.3.4 Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.3.5 Adenium Biotech Recent Development
    11.4 Vaxdyn
        11.4.1 Vaxdyn Company Details
        11.4.2 Vaxdyn Business Overview
        11.4.3 Vaxdyn Acinetobacter Infections Treatment Introduction
        11.4.4 Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.4.5 Vaxdyn Recent Development
    11.5 Hsiri Therapeutics
        11.5.1 Hsiri Therapeutics Company Details
        11.5.2 Hsiri Therapeutics Business Overview
        11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Introduction
        11.5.4 Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.5.5 Hsiri Therapeutics Recent Development
    11.6 Aridis Pharmaceuticals
        11.6.1 Aridis Pharmaceuticals Company Details
        11.6.2 Aridis Pharmaceuticals Business Overview
        11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Introduction
        11.6.4 Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.6.5 Aridis Pharmaceuticals Recent Development
    11.7 LegoChem Biosciences
        11.7.1 LegoChem Biosciences Company Details
        11.7.2 LegoChem Biosciences Business Overview
        11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Introduction
        11.7.4 LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.7.5 LegoChem Biosciences Recent Development
    11.8 Atterx Biotherapeutics
        11.8.1 Atterx Biotherapeutics Company Details
        11.8.2 Atterx Biotherapeutics Business Overview
        11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Introduction
        11.8.4 Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.8.5 Atterx Biotherapeutics Recent Development
    11.9 Achaogen
        11.9.1 Achaogen Company Details
        11.9.2 Achaogen Business Overview
        11.9.3 Achaogen Acinetobacter Infections Treatment Introduction
        11.9.4 Achaogen Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.9.5 Achaogen Recent Development
    11.10 Peptilogics
        11.10.1 Peptilogics Company Details
        11.10.2 Peptilogics Business Overview
        11.10.3 Peptilogics Acinetobacter Infections Treatment Introduction
        11.10.4 Peptilogics Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.10.5 Peptilogics Recent Development
    11.11 Sealife PHARMA
        11.11.1 Sealife PHARMA Company Details
        11.11.2 Sealife PHARMA Business Overview
        11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Introduction
        11.11.4 Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.11.5 Sealife PHARMA Recent Development
    11.12 Shionogi
        11.12.1 Shionogi Company Details
        11.12.2 Shionogi Business Overview
        11.12.3 Shionogi Acinetobacter Infections Treatment Introduction
        11.12.4 Shionogi Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.12.5 Shionogi Recent Development
    11.13 Techulon
        11.13.1 Techulon Company Details
        11.13.2 Techulon Business Overview
        11.13.3 Techulon Acinetobacter Infections Treatment Introduction
        11.13.4 Techulon Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.13.5 Techulon Recent Development
    11.14 Tetraphase Pharmaceuticals
        11.14.1 Tetraphase Pharmaceuticals Company Details
        11.14.2 Tetraphase Pharmaceuticals Business Overview
        11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Introduction
        11.14.4 Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2016-2021)
        11.14.5 Tetraphase Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Sulbactam
    Table 3. Key Players of Carbapenems
    Table 4. Key Players of Aminoglycosides
    Table 5. Key Players of Polymyxins
    Table 6. Key Players of Tetracyclines
    Table 7. Key Players of Others
    Table 8. Global Acinetobacter Infections Treatment Market Size Growth by Pipeline (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Acinetobacter Infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Acinetobacter Infections Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Acinetobacter Infections Treatment Market Share by Regions (2016-2021)
    Table 12. Global Acinetobacter Infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Acinetobacter Infections Treatment Market Share by Regions (2022-2027)
    Table 14. Acinetobacter Infections Treatment Market Trends
    Table 15. Acinetobacter Infections Treatment Market Drivers
    Table 16. Acinetobacter Infections Treatment Market Challenges
    Table 17. Acinetobacter Infections Treatment Market Restraints
    Table 18. Global Acinetobacter Infections Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Acinetobacter Infections Treatment Market Share by Players (2016-2021)
    Table 20. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2020)
    Table 21. Ranking of Global Top Acinetobacter Infections Treatment Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Acinetobacter Infections Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Acinetobacter Infections Treatment Product Solution and Service
    Table 25. Date of Enter into Acinetobacter Infections Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Acinetobacter Infections Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2016-2021)
    Table 29. Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Acinetobacter Infections Treatment Market Size Share by Pipeline (2016-2021) & (US$ Million)
    Table 32. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2016-2021)
    Table 33. Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2022-2027) (US$ Million)
    Table 34. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2022-2027) & (US$ Million)
    Table 35. North America Acinetobacter Infections Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Acinetobacter Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) (US$ Million)
    Table 38. North America Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027) & (US$ Million)
    Table 39. North America Acinetobacter Infections Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Acinetobacter Infections Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Acinetobacter Infections Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Acinetobacter Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) (US$ Million)
    Table 44. Europe Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027) & (US$ Million)
    Table 45. Europe Acinetobacter Infections Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Acinetobacter Infections Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Acinetobacter Infections Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Acinetobacter Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Acinetobacter Infections Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Acinetobacter Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) (US$ Million)
    Table 56. Latin America Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027) & (US$ Million)
    Table 57. Latin America Acinetobacter Infections Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Acinetobacter Infections Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Entasis Therapeutics Company Details
    Table 66. Entasis Therapeutics Business Overview
    Table 67. Entasis Therapeutics Acinetobacter Infections Treatment Product
    Table 68. Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 69. Entasis Therapeutics Recent Development
    Table 70. Roche Company Details
    Table 71. Roche Business Overview
    Table 72. Roche Acinetobacter Infections Treatment Product
    Table 73. Roche Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 74. Roche Recent Development
    Table 75. Adenium Biotech Company Details
    Table 76. Adenium Biotech Business Overview
    Table 77. Adenium Biotech Acinetobacter Infections Treatment Product
    Table 78. Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 79. Adenium Biotech Recent Development
    Table 80. Vaxdyn Company Details
    Table 81. Vaxdyn Business Overview
    Table 82. Vaxdyn Acinetobacter Infections Treatment Product
    Table 83. Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 84. Vaxdyn Recent Development
    Table 85. Hsiri Therapeutics Company Details
    Table 86. Hsiri Therapeutics Business Overview
    Table 87. Hsiri Therapeutics Acinetobacter Infections Treatment Product
    Table 88. Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 89. Hsiri Therapeutics Recent Development
    Table 90. Aridis Pharmaceuticals Company Details
    Table 91. Aridis Pharmaceuticals Business Overview
    Table 92. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product
    Table 93. Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 94. Aridis Pharmaceuticals Recent Development
    Table 95. LegoChem Biosciences Company Details
    Table 96. LegoChem Biosciences Business Overview
    Table 97. LegoChem Biosciences Acinetobacter Infections Treatment Product
    Table 98. LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 99. LegoChem Biosciences Recent Development
    Table 100. Atterx Biotherapeutics Company Details
    Table 101. Atterx Biotherapeutics Business Overview
    Table 102. Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 103. Atterx Biotherapeutics Recent Development
    Table 104. Achaogen Company Details
    Table 105. Achaogen Business Overview
    Table 106. Achaogen Acinetobacter Infections Treatment Product
    Table 107. Achaogen Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 108. Achaogen Recent Development
    Table 109. Peptilogics Company Details
    Table 110. Peptilogics Business Overview
    Table 111. Peptilogics Acinetobacter Infections Treatment Product
    Table 112. Peptilogics Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 113. Peptilogics Recent Development
    Table 114. Sealife PHARMA Company Details
    Table 115. Sealife PHARMA Business Overview
    Table 116. Sealife PHARMA Acinetobacter Infections Treatment Product
    Table 117. Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 118. Sealife PHARMA Recent Development
    Table 119. Shionogi Company Details
    Table 120. Shionogi Business Overview
    Table 121. Shionogi Acinetobacter Infections Treatment Product
    Table 122. Shionogi Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 123. Shionogi Recent Development
    Table 124. Techulon Company Details
    Table 125. Techulon Business Overview
    Table 126. Techulon Acinetobacter Infections Treatment Product
    Table 127. Techulon Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 128. Techulon Recent Development
    Table 129. Tetraphase Pharmaceuticals Company Details
    Table 130. Tetraphase Pharmaceuticals Business Overview
    Table 131. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product
    Table 132. Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2016-2021) & (US$ Million)
    Table 133. Tetraphase Pharmaceuticals Recent Development
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acinetobacter Infections Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Sulbactam Features
    Figure 3. Carbapenems Features
    Figure 4. Aminoglycosides Features
    Figure 5. Polymyxins Features
    Figure 6. Tetracyclines Features
    Figure 7. Others Features
    Figure 8. Global Acinetobacter Infections Treatment Market Share by Pipeline: 2020 VS 2027
    Figure 9. ETX2514 Case Studies
    Figure 10. Nacubactam RG6080 Case Studies
    Figure 11. Arenicin Case Studies
    Figure 12. VXD-001 Case Studies
    Figure 13. Small Molecule Antibiotic Case Studies
    Figure 14. AR-401 mAB Case Studies
    Figure 15. LCB01-0371 (PO) Case Studies
    Figure 16. GN-4474 Case Studies
    Figure 17. Antibacterial Antibody Case Studies
    Figure 18. Others Case Studies
    Figure 19. Acinetobacter Infections Treatment Report Years Considered
    Figure 20. Global Acinetobacter Infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 21. Global Acinetobacter Infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 22. Global Acinetobacter Infections Treatment Market Share by Regions: 2020 VS 2027
    Figure 23. Global Acinetobacter Infections Treatment Market Share by Regions (2022-2027)
    Figure 24. Global Acinetobacter Infections Treatment Market Share by Players in 2020
    Figure 25. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2020
    Figure 26. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2020
    Figure 27. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2016-2021)
    Figure 28. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2022-2027)
    Figure 29. North America Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. North America Acinetobacter Infections Treatment Market Share by Type (2016-2027)
    Figure 31. North America Acinetobacter Infections Treatment Market Share by Pipeline (2016-2027)
    Figure 32. North America Acinetobacter Infections Treatment Market Share by Country (2016-2027)
    Figure 33. United States Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Canada Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Europe Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Europe Acinetobacter Infections Treatment Market Share by Type (2016-2027)
    Figure 37. Europe Acinetobacter Infections Treatment Market Share by Pipeline (2016-2027)
    Figure 38. Europe Acinetobacter Infections Treatment Market Share by Country (2016-2027)
    Figure 39. Germany Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. France Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. U.K. Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Italy Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Russia Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Nordic Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Asia-Pacific Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Asia-Pacific Acinetobacter Infections Treatment Market Share by Type (2016-2027)
    Figure 47. Asia-Pacific Acinetobacter Infections Treatment Market Share by Pipeline (2016-2027)
    Figure 48. Asia-Pacific Acinetobacter Infections Treatment Market Share by Region (2016-2027)
    Figure 49. China Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Japan Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. South Korea Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Southeast Asia Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. India Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Australia Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Latin America Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Latin America Acinetobacter Infections Treatment Market Share by Type (2016-2027)
    Figure 57. Latin America Acinetobacter Infections Treatment Market Share by Pipeline (2016-2027)
    Figure 58. Latin America Acinetobacter Infections Treatment Market Share by Country (2016-2027)
    Figure 59. Mexico Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Brazil Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Middle East & Africa Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Middle East & Africa Acinetobacter Infections Treatment Market Share by Type (2016-2027)
    Figure 63. Middle East & Africa Acinetobacter Infections Treatment Market Share by Pipeline (2016-2027)
    Figure 64. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2016-2027)
    Figure 65. Turkey Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. Saudi Arabia Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 67. UAE Acinetobacter Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 68. Entasis Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 69. Roche Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 70. Adenium Biotech Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 71. Vaxdyn Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 72. Hsiri Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 73. Aridis Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 74. LegoChem Biosciences Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 75. Atterx Biotherapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 76. Achaogen Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 77. Peptilogics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 78. Sealife PHARMA Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 79. Shionogi Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 80. Techulon Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 81. Tetraphase Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
Frequently Asked Questions
Acinetobacter Infections Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acinetobacter Infections Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acinetobacter Infections Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Education Software

Education Software market is segmented by company, region (country), by Type, and by Application. ... Read More